Paper19852033
Prognostic value of symptom burden for overall survival in patients receiving chemotherapy for advanced nonsmall cell lung cancer.
Wang XS and 7 others. Cancer, 2010. Cited by 68 papers, by iCite.
Cite this record
ConductScience Library. Prognostic value of symptom burden for overall survival in patients receiving chemotherapy for advanced nonsmall cell lung cancer. Papers, record 19852033. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/19852033
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Prognostic value of symptom burden for overall survival in patients receiving chemotherapy for advanced nonsmall cell lung cancer.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Carcinoma, Non-Small-Cell Lung | Major topic |
| Lung Neoplasms | Major topic |
| Adult | |
| Aged | |
| Aged, 80 and over | |
| Dyspnea | |
| Fatigue | |
| Female | |
| Humans | |
| Male | |
| Middle Aged | |
| Pain | |
| Prognosis | |
| Prospective Studies | |
| Sleep Wake Disorders |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| R01 CA026582 | NCI NIH HHS | United States | R01CA026582 | PubMed and NIH |
Source NIH RePORTER
References28
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 9587123 | Rapid screening for psychologic distress in men with prostate carcinoma: a pilot study. | Cancer | 1998 | https://conductscience.org/library/papers/9587123 | PubMed |
| 2 | 11013380 | Assessing symptom distress in cancer patients: the M.D. Anderson Symptom Inventory. | Cancer | 2000 | https://conductscience.org/library/papers/11013380 | PubMed |
| 3 | 9817289 | Randomized comparison of four tools measuring overall quality of life in patients with advanced cancer. | J Clin Oncol | 1998 | https://conductscience.org/library/papers/9817289 | PubMed |
| 4 | 18227528 | The prognostic significance of patient-reported outcomes in cancer clinical trials. | J Clin Oncol | 2008 | https://conductscience.org/library/papers/18227528 | PubMed |
| 5 | 12911290 | The role of chemotherapy in the treatment of unresectable stage III and IV nonsmall cell lung cancer. | Respir Care Clin N Am | 2003 | https://conductscience.org/library/papers/12911290 | PubMed |
| 6 | 7561224 | Symptom distress in newly diagnosed ambulatory cancer patients and as a predictor of survival in lung cancer. | J Pain Symptom Manage | 1995 | https://conductscience.org/library/papers/7561224 | PubMed |
| 7 | 12697878 | Early change in patient-reported health during lung cancer chemotherapy predicts clinical outcomes beyond those predicted by baseline report: results from Eastern Cooperative Oncology Group Study 5592. | J Clin Oncol | 2003 | https://conductscience.org/library/papers/12697878 | PubMed |
| 8 | 11195407 | NCCN Practice Guidelines for Cancer Pain. | Oncology (Williston Park) | 2000 | https://conductscience.org/library/papers/11195407 | PubMed |
| 9 | 17951226 | Symptom burden: multiple symptoms and their impact as patient-reported outcomes. | J Natl Cancer Inst Monogr | 2007 | https://conductscience.org/library/papers/17951226 | PubMed |
| 10 | 18048819 | Symptom prevalence, intensity, and distress in patients with inoperable lung cancer in relation to time of death. | J Clin Oncol | 2007 | https://conductscience.org/library/papers/18048819 | PubMed |
| 11 | 7659438 | When is cancer pain mild, moderate or severe? Grading pain severity by its interference with function. | Pain | 1995 | https://conductscience.org/library/papers/7659438 | PubMed |
| 12 | 12719681 | Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. | Med Care | 2003 | https://conductscience.org/library/papers/12719681 | PubMed |
| 13 | 16787687 | Effect of chemotherapy for advanced non-small cell lung cancer on patients' quality of life. A randomized controlled trial. | Lung Cancer | 2006 | https://conductscience.org/library/papers/16787687 | PubMed |
| 14 | 15698531 | Quality-of-life assessment in advanced lung cancer: considerations for evaluation in patients receiving chemotherapy. | Lung Cancer | 2004 | https://conductscience.org/library/papers/15698531 | PubMed |
| 15 | 18241000 | Setting the stage for tailored chemotherapy in the management of non-small cell lung cancer. | Future Oncol | 2008 | https://conductscience.org/library/papers/18241000 | PubMed |
| 16 | 17568038 | ERCC1 and non-small-cell lung cancer. | N Engl J Med | 2007 | https://conductscience.org/library/papers/17568038 | PubMed |
| 17 | 7165009 | Toxicity and response criteria of the Eastern Cooperative Oncology Group. | Am J Clin Oncol | 1982 | https://conductscience.org/library/papers/7165009 | PubMed |
| 18 | 10091805 | The rapid assessment of fatigue severity in cancer patients: use of the Brief Fatigue Inventory. | Cancer | 1999 | https://conductscience.org/library/papers/10091805 | PubMed |
| 19 | 10699541 | Symptoms in adults with lung cancer. A systematic research review. | J Pain Symptom Manage | 2000 | https://conductscience.org/library/papers/10699541 | PubMed |
| 20 | 18158231 | Establishing mild, moderate, and severe scores for cancer-related symptoms: how consistent and clinically meaningful are interference-based severity cut-points? | J Pain Symptom Manage | 2008 | https://conductscience.org/library/papers/18158231 | PubMed |
Cited by41
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 68 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42720799 | Improved quality of life and prolonged survival with add-on homeopathic treatment in patients with non-small cell lung cancer: a prospective, randomized, placebo-controlled, double-blind, three-arm, multicenter study. | Support Care Cancer | 2026 | https://conductscience.org/library/papers/42720799 | PubMed |
| 42036773 | Impact of the Oncologist's Recommendation on Exercise Levels and Quality of Life in Patients With Lung Cancer: The ORE Randomized Controlled Trial. | Cancer Med | 2026 | https://conductscience.org/library/papers/42036773 | PubMed |
| 41834268 | Non-Pharmacological Interventions for Cough in Patients With Lung Cancer: A Systematic Review and Meta-Analysis. | J Clin Nurs | 2026 | https://conductscience.org/library/papers/41834268 | PubMed |
| 41411039 | A Machine Learning Approach to Predicting Mortality Risk in Chemotherapy-Treated Lung Cancer: Machine Learning Model Development and Validation. | JMIR Med Inform | 2025 | https://conductscience.org/library/papers/41411039 | PubMed |
| 40042631 | Shared decision making in routine oncology appointments with Black patients with lung cancer. | Support Care Cancer | 2025 | https://conductscience.org/library/papers/40042631 | PubMed |
| 39862291 | Sleep quality in lung cancer and specifically non-small-cell lung cancer: a rapid review. | Support Care Cancer | 2025 | https://conductscience.org/library/papers/39862291 | PubMed |
| 39644035 | Patient-reported outcomes after CAR T-cell therapy in patients with hematological malignancies. | Hematology Am Soc Hematol Educ Program | 2024 | https://conductscience.org/library/papers/39644035 | PubMed |
| 39281186 | Clinicians' Prediction of Survival Is Most Useful for Palliative Care Referral. | Palliat Med Rep | 2024 | https://conductscience.org/library/papers/39281186 | PubMed |
| 39256698 | Prognosis and risk factor assessment of patients with advanced lung cancer with low socioeconomic status: model development and validation. | BMC Cancer | 2024 | https://conductscience.org/library/papers/39256698 | PubMed |
| 39199563 | Physical Deconditioning in Lung Cancer Patients Who Underwent Lung Resection Surgery in Spain: A Prospective Observational Study. | Cancers (Basel) | 2024 | https://conductscience.org/library/papers/39199563 | PubMed |
| 39177095 | Systemic inflammation and changes in physical well-being in patients with breast cancer: a longitudinal study in community oncology settings. | Oncologist | 2025 | https://conductscience.org/library/papers/39177095 | PubMed |
| 37208661 | Patient-reported outcome (PRO)-based symptom assessment in patients with advanced lung cancer receiving first-line combination immunotherapy: a protocol for a multicenter, prospective, observational study. | BMC Pulm Med | 2023 | https://conductscience.org/library/papers/37208661 | PubMed |
| 36625510 | Quality-of-life outcomes and risk prediction for patients randomized to nivolumab plus ipilimumab vs nivolumab on LungMAP-S1400I. | J Natl Cancer Inst | 2023 | https://conductscience.org/library/papers/36625510 | PubMed |
| 36564827 | Symptom clusters and impact on quality of life in esophageal cancer patients. | Health Qual Life Outcomes | 2022 | https://conductscience.org/library/papers/36564827 | PubMed |
| 36533434 | Racial and ethnic inequities of palliative care use among advanced Non-Small cell lung cancer patients in the US. | Cancer Med | 2023 | https://conductscience.org/library/papers/36533434 | PubMed |
| 36406000 | Pemetrexed and Platinum Plus Pembrolizumab in Patients With Metastatic Nonsquamous NSCLC by Tumor Burden at Baseline: A Post Hoc Efficacy Analysis of KEYNOTE-189. | JTO Clin Res Rep | 2022 | https://conductscience.org/library/papers/36406000 | PubMed |
| 33310772 | Strategies for improving the management of immune-related adverse events. | J Immunother Cancer | 2020 | https://conductscience.org/library/papers/33310772 | PubMed |
| 33163391 | Distinct Subgroups of Patients With Lung Cancer Receiving Chemotherapy: A Latent Transition Analysis. | Front Oncol | 2020 | https://conductscience.org/library/papers/33163391 | PubMed |
| 33010094 | Homeopathic Treatment as an Add-On Therapy May Improve Quality of Life and Prolong Survival in Patients with Non-Small Cell Lung Cancer: A Prospective, Randomized, Placebo-Controlled, Double-Blind, Three-Arm, Multicenter Study. | Oncologist | 2020 | https://conductscience.org/library/papers/33010094 | PubMed |
| 32374469 | Symptom burden trajectories experienced by patients with brain tumors. | Cancer | 2020 | https://conductscience.org/library/papers/32374469 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/19852033
GET https://conductscience.org/api/papers/v1/19852033/references?page=2